APA (7th ed.) Citation

R, B., KE, S., MM, S., A, D., K, L., K, P., . . . E, C. (2025). Lorlatinib and neurocognitive adverse events: Characterization, risk factors, and the potentially mitigative role of social support. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(12), 1134. https://doi.org/10.1007/s00520-025-10182-9

Chicago Style (17th ed.) Citation

R, Brown, et al. "Lorlatinib and Neurocognitive Adverse Events: Characterization, Risk Factors, and the Potentially Mitigative Role of Social Support." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 33, no. 12 (2025): 1134. https://doi.org/10.1007/s00520-025-10182-9.

MLA (9th ed.) Citation

R, Brown, et al. "Lorlatinib and Neurocognitive Adverse Events: Characterization, Risk Factors, and the Potentially Mitigative Role of Social Support." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 33, no. 12, 2025, p. 1134, https://doi.org/10.1007/s00520-025-10182-9.